Skip to content

Opioid Free vs Opioid Based Anesthesia for Laparoscopic Sleeve Gastrectomy

Opioid Free vs Opioid Based Anesthesia for Laparoscopic Sleeve Gastrectomy: Clinical, Randomised Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04260659
Enrollment
59
Registered
2020-02-07
Start date
2020-02-04
Completion date
2023-02-22
Last updated
2023-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Opioid Use, Postoperative Nausea, Postoperative Pain, Postoperative Vomiting

Keywords

Opioid free anesthesia, Laparoscopic sleeve gastrectomy

Brief summary

Opioid free anesthesia is an anesthetic technique, in which administration of multimodal analgesia and sympathicolytics provides hemodynamic stability without use of opioids. Such management may be beneficial to the obese patients undergoing laparoscopic sleeve gastrectomy. Our study aims to compare opioid free anesthesia in such patients with standard, short-acting opioid based.

Detailed description

The study has been approved by Bioethical Committee of Medical University of Warsaw. Informed written consent will be obtained from all patients. Sample size of 60 patients has been calculated based on the Altman normogram to obtain 30% reduction of postoperative opioid consumption with significance and power of 90%. Consenting patients scheduled for laparoscopic sleeve gastrectomy will be randomly assigned to the computer generated list to receive opioid free or standard opioid based anesthesia. Opioid free protocol includes administration of dexmedetomidine, lidocaine, ketamine, magnesium sulphate whereas standard group will receive remifentanil TCI Minto Model. After the end of operation all of the patient will receive oxycodone and additional doses via PCA system for postoperative analgesia.

Interventions

DRUGDexmedetomidine Hydrochloride [Dexdor]

Initial dosis of dexmedetomidine 1 mcg/kg IBW iv will be administered within 10 minutes before general anesthesia induction. Following intubation infusion of 1 mcg/kg IBW / h will be initiated and continued until the end of operation.

DRUGRemifentanil [Ultiva]

Remifentanil TCI Minto Model will be used during induction in dosis 6 ng/ml and intraoperatively appropriately to maintain hemodynamical stability.

DRUGKetamine [Ketalar]

Ketamine 0,5mg/kg IBW iv will be administered during induction of general anesthesia.

DRUGLidocaine [Xylocaine 2%]

Initial dosis of lidocaine 1,5 mg/kg IBW iv will be administered within 10 minutes before general anesthesia induction. Following intubation infusion of 3 mg/kg IBW / h will be initiated and continued until the end of operation.

DRUGMagnesium Sulphate [Inj. Magnesii Sulfurici Polpharma]

Magnesium Sulphate will be administered in dosis 50 mg/kg IBW iv intraoperatively.

DRUGFentanyl [Fentanyl WZF]

Rescue dosis of 100 mcg iv will be administered if hypertension \> 140/90 mmHg or tachycardia \> 120min occurs. If necessary rescue dosis may be repeated.

Sponsors

Medical University of Warsaw
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Sleeve gastrectomy in patients with BMI \> 40 or \>35 with comorbidities * Written informed consent

Exclusion criteria

* Patient's refusal * Known allergies to study medication * Inability to comprehend or participate In pain scoring scale * Inability to use intravenous patient controlled analgesia * Changes of operation extent during procedure * Revisional operations

Design outcomes

Primary

MeasureTime frameDescription
Total postoperative oxycodone consumptionDay 0PCA (Patient's controlled analgesia) iv pump, oxycodone will be administered on patient's demand by 2mg boli, with lock out time 10 minutes
Postoperative pain score in NRS scaleDay 0, assessed 1 hour after operationNRS range from 0 for no pain to 10 for worst pain imaginable

Secondary

MeasureTime frameDescription
Rescue fentanyl administration dosisintraoperativeIn opioid free group, rescue fentanyl dosis will be administered if hypertension \> 140/90 mmHg or tachycardia \> 120/min occurs
Highest BPintraoperativeHighest BP during operation
Lowest BPintraoperativeLowest BP during operation
Highest HRintraoperativeHighest HR during operation
Postoperative sedation scoreDay 0, assessed 1,6,12 and 24 hours after operation1-6 Ramsay sedation score; 1 - agitated or restless 6 - unresponsive
Total ephedrine dosisintraoperativeEphedrine is a vasopressor used in case of hypotension to maintain mean arterial pressure \> 65 mmHg or to increase blood pressure to check surgical hemostasis
Postoperative desaturationDay 0, assessed 1,6,12 and 24 hours after operationSpO2 \< 94%
Patient's comfort assessed in QoR-40 formulary7 days postoperativelyQoR-40 scale is used to measure the quality of recovery after surgery and anesthesia, it is a 40 item questionnaire that provides a score across five dimensions: patient support, comfort, emotions, physical independence, and pain. Formulary will assess first 24 hours following the operation and will be filled by the patient 7 days after operation
Lowest HRintraoperativeLowest HR during operation
Postoperative nausea and vomitingDay 0, assessed 1,6,12 and 24 hours after operationSimplified PONV impact scale 0-6 0 - no nausea nor vomiting 6 - \>3 episodes of vomiting and nausea all of the time

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026